Relationships between Serum Luteinizing Hormone Level, Endometrial Thickness and Body Mass Index in Polycystic Ovary Syndrome Patients with and without Endometrial Hyperplasia

被引:0
|
作者
Ramezanali, Fariba [1 ]
Khalili, Gholamreza [2 ]
Arabipoor, Arezoo [1 ]
Lankarani, Narges Bagheri [2 ]
Moini, Ashraf [1 ]
机构
[1] ACECR, Royan Inst Reprod Biomed, Reprod Biomed Res Ctr, Dept Endocrinol & Female Infertil, POB 16635-148, Tehran, Iran
[2] ACECR, Royan Inst Reprod Biomed, Reprod Epidemiol Res Ctr, Dept Epidemiol & Reprod Hlth, Tehran, Iran
关键词
Polycystic Ovary Syndrome; Endometrial Hyperplasia; Luteinizing Hormone; Body Mass Index;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The endometrial hyperplasia measured by ultrasound in polycystic ovary syndrome (PCOS) women is strongly related to pathologic endometrial thickness, but there is no consensus on the relation between serum luteinizing hormone (LH) and either of these factors: pathologic endometrial hyperplasia and body mass index (BMI). Materials and Methods: In this observational cross-sectional study, three hundred fifty infertile PCOS women were involved in this research. An endometrial biopsy was taken by using a pipelle instrument, regardless of menstrual cycle's day and all samples were reported by the same pathologist. Basal serum LH level was compared between two subgroups (hyperplasia and non-hyperplasia). The intended population was divided into three groups according to BMI and basal serum LH, later on the comparison was made in three groups. Chi-square test was applied to compare nominal variables between groups. Mann-Whitney U, and one way ANOVA tests were used to compare means on the basis of the result of normality test. Results: The frequency of endometrial hyperplasia was 2.6%. Endometrial thickness in the patients with endometrial hyperplasia was significantly higher than that of a normal endometrium (10.78 +/- 3.70 vs. 7.90 +/- 2.86 respectively, P=0.020). There was no relation between endometrial hyperplasia and serum LH (P=0.600). The ANOVA test showed serum LH levels were not the same among three BMI groups (P=0.007). Post hoc test was also performed. It showed that the LH level in normal BMI group was significantly higher than those of other groups (P=0.005 and P=0.004), but there was no statistical difference between overweight and obese groups (P=0.8). We found no relationship between BMI and endometrial thickness in PCOS patients (P=0.6). Conclusion: Sonographic endometrial stripe thickness is predictive for endometrial hyperplasia in PCOS women. We could not find out any relationship between serum LH level and BMI with endometrial thickness in PCOS patients. However, our study confirmed a diverse relationship between serum LH level and BMI in PCOS patients.
引用
收藏
页码:36 / 41
页数:6
相关论文
共 50 条
  • [1] Endometrial thickness predicts endometrial hyperplasia in patients with polycystic ovary syndrome
    McCormick, Betsy A.
    Wilburn, Rochelle D.
    Thomas, Michael A.
    Williams, Daniel B.
    Maxwell, Rose
    Aubuchon, Mira
    FERTILITY AND STERILITY, 2011, 95 (08) : 2625 - 2627
  • [2] Endometrial stripe and body mass index are independent predictors of endometrial hyperplasia in patients with polycystic ovarian syndrome.
    McCormick, B. A.
    Wilburn, R.
    Thomas, M. A.
    Aubuchon, M.
    Maxwell, R.
    Williams, D. B.
    FERTILITY AND STERILITY, 2006, 86 : S451 - S451
  • [3] Correlation between Body Mass Index and Serum Leptin Level in Patients with Polycystic Ovary Syndrome
    Jupri, Erna
    Tjandrawati, Anna
    Bayuaji, Hartanto
    Rachmayati, Sylvia
    Parwati, Ida
    MAJALAH KEDOKTERAN BANDUNG-MKB-BANDUNG MEDICAL JOURNAL, 2019, 51 (03): : 154 - 159
  • [4] High Fat Mass Index is Associated with Endometrial Hyperplasia in Polycystic Ovary Syndrome Patients: A Retrospective Study
    Kuai, Dan
    Li, Mengying
    He, Ling
    Li, Xiaoyan
    He, Ying
    Liu, Shiqi
    Wei, Jiayu
    Ji, Xia
    Wang, Yingmei
    Tian, Wenyan
    Zhang, Huiying
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2024, 16 : 2065 - 2075
  • [5] Antimullerian hormone, endometrial thickness in predicting follicular maturation in Polycystic Ovary syndrome
    Omer, A.
    Nabag, W.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 188 - 188
  • [6] Leptin levels in serum depending on Body Mass Index in patients with endometrial hyperplasia and cancer
    Cymbaluk, Aneta
    Chudecka-Glaz, Anita
    Rzepka-Gorska, Izabella
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2008, 136 (01) : 74 - 77
  • [7] Analysis on Reverse of Atypical Endometrial Hyperplasia by Drugs in Patients with Polycystic Ovary Syndrome
    Xiao-fang LOU
    Jin-fang LIN
    Su-ping FANG
    Feng-ling WANG
    Journal of Reproduction and Contraception, 2013, (04) : 205 - 214
  • [8] UTERINE VOLUME AND ENDOMETRIAL THICKNESS IN THE EARLY FOLLICULAR PHASE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME
    Panidis, Dimitrios
    Tziomalos, Konstantinos
    Papadakis, Efstathios
    Vosnakis, Christos
    Betsas, Georgios
    Tsourdi, Ekaterini
    Katsikis, Ilias
    ENDOCRINE PRACTICE, 2014, 20 (06) : 540 - 547
  • [9] Relationship between body mass index and endothelial dysfunction in women with and without polycystic ovary syndrome
    Adler, Tessa E.
    Usselman, Charlotte W.
    Anaeto, Laura C.
    Schapiro, Rebecca G.
    Steele, Frances E.
    Toffoloni, Nikoletta
    Takamata, Akira
    Taylor, Hugh S.
    Stachenfeld, Nina S.
    FASEB JOURNAL, 2017, 31
  • [10] Effect of Body Mass Index on Endometrial Thickness in Postmenopausal Asymptomatic Patients
    Yurtsever, Cigdem Yavuz
    Aydin, Derya Sivri
    Guldas, Ahmet
    Ateser, Guler
    Bacanakgil, Besim Haluk
    Boran, Ahmet Birtan
    ISTANBUL MEDICAL JOURNAL, 2015, 16 (01): : 14 - 17